ZA935647B - Treatment of sickle cell disease - Google Patents
Treatment of sickle cell diseaseInfo
- Publication number
- ZA935647B ZA935647B ZA935647A ZA935647A ZA935647B ZA 935647 B ZA935647 B ZA 935647B ZA 935647 A ZA935647 A ZA 935647A ZA 935647 A ZA935647 A ZA 935647A ZA 935647 B ZA935647 B ZA 935647B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- sickle cell
- cell disease
- disease
- sickle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929216506A GB9216506D0 (en) | 1992-08-04 | 1992-08-04 | Improvements in or relating to the treatment of sickle cell disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935647B true ZA935647B (en) | 1995-02-06 |
Family
ID=10719768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935647A ZA935647B (en) | 1992-08-04 | 1993-08-04 | Treatment of sickle cell disease |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4719793A (xx) |
GB (2) | GB9216506D0 (xx) |
WO (1) | WO1994003169A1 (xx) |
ZA (1) | ZA935647B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE299135T1 (de) * | 1995-09-29 | 2005-07-15 | Novartis Pharma Gmbh | Hydroxypyridinone |
US6087398A (en) * | 1996-03-01 | 2000-07-11 | South Alabama Medical Science Foundation | Sickle cell anemia treatment |
IT1312086B1 (it) * | 1999-04-21 | 2002-04-04 | Zambon Spa | Uso della nac per la preparazione di un medicamento adatto allasomministrazione endovenosa per la prevenzione dello stress |
DE10160796A1 (de) * | 2001-12-11 | 2003-06-26 | Wulf Droege | Verwendung einer Cystein-haltigen Substanz zur Steigerung der Atmungsaktivität und Erythropoetin-Produktion |
WO2010045220A1 (en) | 2008-10-14 | 2010-04-22 | Edison Pharmaceuticals, Inc. | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
CN102190644B (zh) * | 2011-03-31 | 2012-11-21 | 浙江大学 | 手性3-羟基吡啶-4-酮类衍生物及其合成和用途 |
EP3960168A1 (en) * | 2020-08-28 | 2022-03-02 | Université de Genève | Compositions and methods comprising d-cysteine or a derivative thereof |
-
1992
- 1992-08-04 GB GB929216506A patent/GB9216506D0/en active Pending
-
1993
- 1993-08-02 AU AU47197/93A patent/AU4719793A/en not_active Abandoned
- 1993-08-02 GB GB9316004A patent/GB2269748A/en not_active Withdrawn
- 1993-08-02 WO PCT/GB1993/001626 patent/WO1994003169A1/en active Application Filing
- 1993-08-04 ZA ZA935647A patent/ZA935647B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB9216506D0 (en) | 1992-09-16 |
WO1994003169A1 (en) | 1994-02-17 |
GB9316004D0 (en) | 1993-09-15 |
GB2269748A (en) | 1994-02-23 |
AU4719793A (en) | 1994-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9000206A0 (en) | Treatment of conditions & diseases | |
HU9300536D0 (en) | Compounds of medical effect | |
GB8606913D0 (en) | Treatment of sickle cell disease | |
AP9200358A0 (en) | Orthomolecular method of treating sickle cell disease | |
ZA935647B (en) | Treatment of sickle cell disease | |
GB9222260D0 (en) | Skin treatment | |
GB9201920D0 (en) | Novel treatment i | |
ZA914435B (en) | Treatment of disease | |
IL104755A0 (en) | Treatment of glaucoma | |
IL107768A0 (en) | Treatment of agricultural produce | |
GB9217124D0 (en) | Medical treatment | |
GB9220194D0 (en) | Medical electrode | |
ZA9189B (en) | Treatment of protozoal diseases | |
GB9216360D0 (en) | Treatment of blood | |
ZA936136B (en) | Treatment of skin diseases | |
GB8707427D0 (en) | Treatment of dandruff | |
AU7695891A (en) | Treatment of autoimmune diseases | |
GB9218773D0 (en) | Skin treatment | |
GB9210477D0 (en) | Treatment of hay | |
GB2266241B (en) | Treatment of pastures | |
GB8829366D0 (en) | Treatment of disease | |
GB9222195D0 (en) | Medical treatment | |
GB9204062D0 (en) | Medical treatment | |
GB9206289D0 (en) | Medical treatment pack | |
GB8827028D0 (en) | Crop treatment |